Here, we provide evidence that LPD is a novel PPARγ agonist and ameliorates cognitive deficits through PPARγ-dependent enhancement of mitophagy and glucose metabolism in the hippocampus of APP/PS1 mice. Here, PSEN1 is linked to disseminated peritoneal leiomyomatosis.